|
Jackie,
Because of the wording In the Menendez abstract (randomized double-blind placebo-controlled clinical trial suggesting that ALA ) I doubt he refers to an experiment on cells but more likely on humans.
In the full text of the results of his previous study comparing the effects of EPA,DHA,ALA he does not use this wording.
One missing piece of research data which may be important for patients is what effect on ER+ cancer cells has supplementation with anyone of the fatty acids targetting HER2+ cells. This can be a concern for two reasons: first, both types of cells may be present in a patient (as opposed to single type cells in lab experiments) & second, some supplements may comprise phytoestrogens whose effect may be either beneficial or detremental depending on circumstances such as disease status (precancerous, primary, metastatic).
An other missing piece of data, more for rigorous scientific purposes than for actual expectations of finding unexpected side effects, would be to submit healthy cells to high doses of the fatty acids.
This said, I still would like to have to have access to the exact referenced clinical trial in the Menendez abstract.
Anyone knows?
|
Hybrid Mode
